Moderna Posts Loss, Citing Seasonality of Respiratory Business
In This Article:
Moderna logged a first-quarter loss as revenue fell, dragged down by lower product sales, though the company said it expects demand to increase during cold and flu season later this year.
Terms and Privacy Policy